New England Journal of Medicine Publishes Novavax’ NanoFlu Clinical Trial Data

NanoFluTM Phase 1/2 trial data published in a peer-reviewed letter to the editor in The New England Journal of Medicine NanoFlu demonstrates significantly improved immune responses against a panel of homologous and drifted A influenza viruses compared ...
Continue reading » · Written on: 06-14-18 · No Comments »